Cargando…
Nanocurcumin–pyrroloquinoline formulation prevents hypertrophy–induced pathological damage by relieving mitochondrial stress in cardiomyocytes under hypoxic conditions
This study investigates the therapeutic effect of a nanocurcumin formulation (NCF) containing nanocurcumin (NC) and pyrroloquinoline quinone (PQQ) on ameliorating hypoxia-induced stress in hypertrophied primary human ventricular cardiomyocytes (HVCM) under hypoxic conditions, as validated in a Sprag...
Autores principales: | Nehra, Sarita, Bhardwaj, Varun, Bansal, Anju, Chattopadhyay, Pronobesh, Saraswat, Deepika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750470/ https://www.ncbi.nlm.nih.gov/pubmed/29611541 http://dx.doi.org/10.1038/emm.2017.199 |
Ejemplares similares
-
Nanocurcumin Prevents Hypoxia Induced Stress in Primary Human Ventricular Cardiomyocytes by Maintaining Mitochondrial Homeostasis
por: Nehra, Sarita, et al.
Publicado: (2015) -
Effects of pyrroloquinoline quinone and imidazole pyrroloquinoline on biological activities and neural functions
por: Yamada, Yasue, et al.
Publicado: (2020) -
Pyrroloquinoline quinone modulates YAP-related anti-ferroptotic activity to protect against myocardial hypertrophy
por: Zhou, Jiabin, et al.
Publicado: (2022) -
In-silico screening and in-vitro validation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) inhibitors
por: Saraswat, Deepika, et al.
Publicado: (2014) -
Injectable Nanocurcumin-Formulated Chitosan-g-Pluronic Hydrogel Exhibiting a Great Potential for Burn Treatment
por: Dang, Le Hang, et al.
Publicado: (2018)